Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response.
Ruiz-Malagón AJ, Hidalgo-García L, Rodríguez-Sojo MJ, Molina-Tijeras JA, García F, Diez-Echave P, Vezza T, Becerra P, Marchal JA, Redondo-Cerezo E, Hausmann M, Rogler G, Garrido-Mesa J, Rodríguez-Cabezas ME, Rodríguez-Nogales A, Gálvez J.
Ruiz-Malagón AJ, et al. Among authors: garrido mesa j.
Biomed Pharmacother. 2023 Jul;163:114760. doi: 10.1016/j.biopha.2023.114760. Epub 2023 Apr 27.
Biomed Pharmacother. 2023.
PMID: 37119741
Free article.